"My challenge is to drive sales growth of our products in a market gripped by two anti-growth forces: increasing competition and decreasing access to sales opportunities"- Trace Cawley, Sales & Marketing of Spinal Products at the Kyocera Medical Technologies, Inc. in Texas, U.S.A.
The U.S. orthopedic implants market makes up roughly 60% of the global market, comprising a large number of players with products becoming more commoditized.
KMTI is a U.S.-based company that develops and sells orthopedic implants such as spinal and joint implants. Kyocera has a rich history of developing advanced technologies that stand apart from competitors and open new market segments. KMTI is evaluating several advanced technologies that not only complement our existing products, but also open entirely new business segments which will allow us to grow rapidly, unchallenged, and with much greater profitability.
Learn more about KMTI here:
https://kyocera-medical.com/
Learn more about Kyocera's operations in the medical and healthcare markets by watching the video below:
https://global.kyocera.com/company/movie/index.html
Related News
-
News
Kyocera Plans New Manufacturing Plant in Japan's Nagasaki Prefecture by 2026
-
Osteon Digital
-
Accelerating developments with next-generation semiconductor and electronic components solutions
-
My Favorite Engineer Interview #4: Deguchi from Kyocera Japan
-
My Favorite Engineer Interview #3: Kevin from Kyocera Japan
-
My Favorite Engineer Interview #2: Katrina from Kyocera Japan
-
Aquala technology for Artificial Joints
-
Aquala technology for Artificial Joints
-
Developing a medtech wearable headset for patients recovering from COVID19
-
News
Information regarding compromise on FENICS
-
News
Support to Victims of the Earthquake in Turkey and Syria
-
Boast and Make it Come True
Related SitesDirect site link
Related Videos